Is this a death knell for anti-interleukin-5 therapy in asthma?

被引：0
|
作者：
Phillip Lieberman
机构：
来源：
Current Allergy and Asthma Reports | 2009年 / 9卷 / 1期
关键词：
Asthma; Respir Crit; Beclomethasone; Exacerbation Rate; Sputum Eosinophil;
D O I：
10.1007/s11882-009-0006-5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series
    Dupin, Clairelyne
    Valery, Solene
    Guilleminault, Laurent
    Devouassoux, Gilles
    Merveilleau, Marine
    Russier, Maud
    Mourin, Gisele
    Pradelli, Johana
    Bonniaud, Philippe
    Le Brun, Mathilde
    Ebstein, Esther
    Juge, Pierre-Antoine
    Lillo-Lelouet, Agnes
    Taille, Camille
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [22] Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma
    Hilvering, Bart
    Xue, Luzheng
    Pavord, Ian D.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 135 - 145
  • [23] Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma
    Kroes, Johannes A.
    Zielhuis, Sybrand W. J.
    De Jong, Kim
    Hashimoto, Simone
    Sont, Jacob K.
    Zielhuis, Sander W.
    Roon, Eric N. Van
    Bel, Elisabeth H.
    Ten Brinke, Anneke
    RAPSODI Team
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (05)
  • [24] Improved small airway dysfunction in severe asthma with clinical remission by anti-interleukin-5/interleukin-5 receptor α
    Akamatsu, Taisuke
    Shirai, Toshihiro
    Okawa, Kohei
    Hirai, Keita
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (05) : 648 - 650
  • [25] NOVEL USE OF ANTI-INTERLEUKIN-5 THERAPY, MEPOLIZUMAB, IN CHRONIC EOSINOPHILIC PNEUMONIA
    Lam, W.
    Ramsey, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S68 - S68
  • [26] Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?
    Castro, Mario
    Bacharier, Leonard B.
    LANCET, 2016, 388 (10056): : 2059 - 2060
  • [27] Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
    Agumadu, Vivian C.
    Ramphul, Kamleshun
    Mejias, Stephanie G.
    Sonaye, Ruhi
    Sombans, Shaheen
    Lohana, Petras
    CUREUS, 2018, 10 (08):
  • [28] Anti-Interleukin-5 Therapy in Patients with Asthma and Chronic Obstructive Pulmonary Disease Overlap: A Single-Center Review
    Saint-Pierre, M. D.
    Mavromatis, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
    Liu, Yao
    Zhang, Song
    Li, Dao-wei
    Jiang, Shu-juan
    PLOS ONE, 2013, 8 (03):
  • [30] Anti-Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry
    Graff, Sophie
    Brusselle, Guy
    Hanon, Shane
    Sohy, Carine
    Dupont, Lieven
    Peche, Rudy
    Michils, Alain
    Pilette, Charles
    Joos, Guy
    Lahousse, Lies
    Lapperre, Therese
    Louis, Renaud
    Schleich, Florence
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 467 - 477
12345